Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2018-02-26
2018-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tDCS in Adults With ASD and/or ADHD Without Intellectual Disability
NCT06946433
Transcranial Direct Current Stimulation in Autistic Spectrum Disorder
NCT05311982
Cortical Excitability and Role of Non Invasive Brain Stimulation in ADHD and AUTISM
NCT07315217
Transcranial Direct Current Stimulation and Autism
NCT01603225
TMS for Adults With Autism and Depression
NCT02939560
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transcranial direct current stimulation (tDCS) - anodal
Transcranial direct current stimulation - anodal (positive) 1.5 millamps for 15 minutes
Transcranial direct current stimulation (tDCS)
Transcranial Direct Current Stimulation (tDCS, a form of non-invasive brain stimulation) on the left dorsolateral prefrontal cortex (DLPFC)
Transcranial direct current stimulation (tDCS) - cathodal
Transcranial direct current stimulation - cathodal (negative) 1.5 millamps for 15 minutes
Transcranial direct current stimulation (tDCS)
Transcranial Direct Current Stimulation (tDCS, a form of non-invasive brain stimulation) on the left dorsolateral prefrontal cortex (DLPFC)
Transcranial direct current stimulation (tDCS) - sham
Transcranial direct current stimulation - sham session 15 minutes
Transcranial direct current stimulation (tDCS)
Transcranial Direct Current Stimulation (tDCS, a form of non-invasive brain stimulation) on the left dorsolateral prefrontal cortex (DLPFC)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial direct current stimulation (tDCS)
Transcranial Direct Current Stimulation (tDCS, a form of non-invasive brain stimulation) on the left dorsolateral prefrontal cortex (DLPFC)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* right handed
* speaks English fluently
* normal vision or corrected to normal
* passing tDCS safety screening
Exclusion Criteria
* participants that have ever suffered from epilepsy, febrile convulsions in infancy or had recurrent fainting spells
* family history of epilepsy
* has a heart pacemaker, cochlear implant, medication pump, surgical clips
* has drunk more than 3 units of alcohol in the last 24 hours
* suffers from migraines
* metal in the head, implanted brain medical devices
* has undergone a neurosurgical procedure
* has had more than one cup of coffee, or other sources of caffeine in the last hour
* taking any unprescribed or prescribed medication that might effect tDCS
* medications or psychoactive drugs that can lower seizure threshold \[imipramine, amitriptyline, doxepine, nortriptyline, maprotiline, chlorpromazine, clozapine, foscarnet, ganciclovir, ritonavir, amphetamines, cocaine, (MDMA, ecstasy), phencyclidine (PCP, angel dust), ketamine, gamma-hydroxybutyrate (GHB), alcohol, theophylline\]
* withdrawal from alcohol, barbiturates, benzodiazepines, meprobamate, chloral hydrate
18 Years
35 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Glasgow
OTHER
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Craig Melville, MD
Role: STUDY_DIRECTOR
University of Glasgo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Glasgow
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN17MH365
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.